Pioglitazole and metformin hydrochloride 850 mg/1

Pioglitazone and metformin hydrochloride 850 mg/1 tablets combine two antidiabetic agents for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Pioglitazone and metformin hydrochloride 850 mg/1 tablets are commonly used to manage type 2 diabetes. These tablets work by improving insulin sensitivity and reducing glucose production in the liver. They are often prescribed when diet and exercise alone are not enough to control blood sugar levels. This combination therapy may help lower the risk of diabetes-related complications when used as directed.

Common effects of pioglitazone and metformin hydrochloride 850 mg/1 tablets may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience weight gain or fluid retention. These effects vary and are not universal, but consulting a healthcare provider if they persist or worsen is advisable.

Handle pioglitazone and metformin hydrochloride 850 mg/1 tablets with care, especially if you have liver or kidney issues. Regular monitoring of blood sugar levels is important. Avoid alcohol, as it can increase the risk of lactic acidosis. Store the tablets at room temperature, away from moisture and heat.

Pioglitazone and metformin hydrochloride 850 mg/1 tablets may interact with certain medications, including other diabetes drugs, insulin, and some antibiotics. Alcohol and certain heart or blood pressure medications can also affect how this combination therapy works. Always inform your healthcare provider about all medications you are taking.